[The influence of molecular classification of breast cancer on the safety of breast-conserving surgery].

Li, Y; Mu, L; Ruan, Y X; Wang, Y T; Zhang, D; Zhou, H; Wang, X

Li, Y; Mu, L; Ruan, Y X; Wang, Y T; Zhang, D; Zhou, H; Wang, X.

Afiliação

Li Y; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Key Laboratory of Breast Cancer Prevention and Therapy, T
Mu L; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Key Laboratory of Breast Cancer Prevention and Therapy, T
Ruan YX; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Key Laboratory of Breast Cancer Prevention and Therapy, T
Wang YT; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Key Laboratory of Breast Cancer Prevention and Therapy, T
Zhang D; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Key Laboratory of Breast Cancer Prevention and Therapy, T
Zhou H; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Key Laboratory of Breast Cancer Prevention and Therapy, T
Wang X; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Key Laboratory of Breast Cancer Prevention and Therapy, T

Zhonghua Zhong Liu Za Zhi ; 40(5): 341-346, 2018 May 23.

Article em Zh | MEDLINE | ID: mdl-29860760

Assuntos

Neoplasias da Mama/classificação; Neoplasias da Mama/cirurgia; Mastectomia Segmentar/efeitos adversos; Tratamentos com Preservação do Órgão/efeitos adversos; Adulto; Idoso; Neoplasias da Mama/genética; Neoplasias da Mama/patologia; Feminino; Humanos; Metástase Linfática; Pessoa de Meia-Idade; Recidiva Local de Neoplasia; Tratamentos com Preservação do Órgão/métodos; Prognóstico; Receptor ErbB-2; Estudos Retrospectivos; Taxa de Sobrevida; Neoplasias de Mama Triplo Negativas/mortalidade; Neoplasias de Mama Triplo Negativas/cirurgia

Palavras-chave

Breast conserving therapy; Breast neoplasms; Metastasis; Molecular classification; Prognosis; Recurrence

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mastectomia Segmentar / Tratamentos com Preservação do Órgão Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: Zh Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google